We are live on ! Find out more
Highlander Partners

Highlander Partners Portfolio holdings

AUM $298M Turnover 6.52%
1-Year Est. Return 53.88%
This Fund
S&P 500
This Quarter Est. Return
-8.24%
1 Year Est. Return
+53.88%
3 Year Est. Return
+240.8%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$76M
AUM Growth
-$3.74M
Cap. Flow
+$7.1M
Cap. Flow %
9.35%
Top 10 Hldgs %
84.18%
Holding
25
New
2
Increased
4
Reduced
2
Closed
1
Avg Time Held
0.5 years
Top 10 Avg Time Held
0.4 years
Top 20 Avg Time Held
0.5 years

Top Buys

Rank Stock Value
1
UTZ icon
Utz Brands
UTZ
+$7.62M
2
YMM icon
Full Truck Alliance
YMM
+$1.44M
3
AMZN icon
Amazon
AMZN
+$1.16M
4
VRT icon
Vertiv
VRT
+$453K
5
NOA icon
North American Construction
NOA
+$248K

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$3.05M
2
BABA icon
Alibaba
BABA
+$657K
3
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$235K

Sector Composition

Rank Sector Weight
1 Financials 30.1%
2 Technology 21.72%
3 Consumer Discretionary 21.25%
4 Consumer Staples 9.97%
5 Healthcare 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
BX icon
1
Blackstone
BX
$95.6B
$12.8M 16.81%
140,000
– –
2021 Q4
2 quarters
YMM icon
2
Full Truck Alliance
YMM
$9.5B
$11.6M 15.26%
1,279,800
+212,000
+20% +$1.44M
2021 Q4
2 quarters
AMZN icon
3
Amazon
AMZN
$2.8T
$8.54M 11.24%
80,400
+9,300
+13% +$1.16M
2021 Q4
2 quarters
UTZ icon
4
Utz Brands
UTZ
$1.26B
$7.58M 9.97%
+548,449
New +$7.62M
2022 Q2
0 quarters
TCBI icon
5
Texas Capital Bancshares
TCBI
$4.39B
$5.26M 6.93%
100,000
– –
2021 Q4
2 quarters
BABA icon
6
Alibaba
BABA
$272B
$5.2M 6.84%
45,700
-6,700
-13% -$657K
2021 Q4
2 quarters
BMY icon
7
Bristol-Myers Squibb
BMY
$127B
$4.62M 6.08%
60,000
-40,000
-40% -$3.05M
2021 Q4
2 quarters
JPM icon
8
JPMorgan Chase
JPM
$888B
$3.27M 4.3%
29,000
– –
2021 Q4
2 quarters
VRT icon
9
Vertiv
VRT
$70.4B
$2.75M 3.61%
334,031
+40,000
+14% +$453K
2021 Q4
2 quarters
MIRM icon
10
Mirum Pharmaceuticals
MIRM
$6.12B
$2.39M 3.15%
122,980
– –
2021 Q4
2 quarters
INTC icon
11
Intel
INTC
$299B
$2.24M 2.95%
60,000
– –
2021 Q4
2 quarters
KEYS icon
12
Keysight
KEYS
$46.3B
$2.07M 2.72%
15,000
– –
2021 Q4
2 quarters
SPY icon
13
State Street SPDR S&P 500 ETF Trust
SPY
$780B
$1.56M 2.06%
4,144
– –
2021 Q4
2 quarters
LOW icon
14
Lowe's Companies
LOW
$126B
$1.44M 1.9%
8,250
– –
2021 Q4
2 quarters
YJ icon
15
Yunji
YJ
$5.52M
$975K 1.28%
23,435
– –
2021 Q4
2 quarters
XHG icon
16
XChange TEC
XHG
$173M
$874K 1.15%
29
+6
+26% +$112K
2021 Q4
2 quarters
AVID
17
DELISTED
Avid Technology Inc
AVID
$597K 0.79%
23,009
– –
2021 Q4
2 quarters
CWST icon
18
Casella Waste Systems
CWST
$6.25B
$509K 0.67%
7,000
– –
2021 Q4
2 quarters
BRK.B icon
19
Berkshire Hathaway Class B
BRK.B
$1.22T
$362K 0.48%
1,325
– –
2021 Q4
2 quarters
WTM icon
20
White Mountains Insurance
WTM
$5.35B
$336K 0.44%
270
– –
2021 Q4
2 quarters
GHC icon
21
Graham Holdings Company
GHC
$5.05B
$303K 0.4%
535
– –
2021 Q4
2 quarters
OMCL icon
22
Omnicell
OMCL
$1.72B
$284K 0.37%
2,500
– –
2021 Q4
2 quarters
CABO icon
23
Cable One
CABO
$24.4M
$257K 0.34%
199
– –
2021 Q4
2 quarters
NOA icon
24
North American Construction
NOA
$247M
$212K 0.28%
+19,186
New +$248K
2022 Q2
0 quarters
ACWI icon
25
iShares MSCI ACWI ETF
ACWI
$31.5B
– –
-2,360
Closed -$235K –

Similar funds

Highlander Partners's Q2 2022 Portfolio in Review

As of Q2 2022, Highlander Partners held 25 positions worth $76M, down 4.7% from $79.7M the previous quarter. Its ten largest holdings account for 84% of the portfolio.

Highlander Partners deployed $7.1M of net new capital in Q2 2022, opening 2 new positions and adding to 4 existing holdings. Its largest new stake was Utz Brands: 548,449 shares worth $7.58M.

By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $3.05M trimmed.

  • Highlander Partners's largest Q2 2022 buy was Utz Brands: 548,449 shares worth $7.58M.
  • Highlander Partners added most to Full Truck Alliance in Q2 2022, an estimated $1.44M increase.
  • Highlander Partners's biggest Q2 2022 reduction was Bristol-Myers Squibb, cutting an estimated $3.05M.
  • Highlander Partners fully exited iShares MSCI ACWI ETF in Q2 2022, selling an estimated $235K.
  • Highlander Partners's ten largest holdings make up 84% of its $76M portfolio in Q2 2022.
  • Highlander Partners opened 2 new positions and closed 1 in Q2 2022.
  • Highlander Partners's portfolio value fell 4.7% quarter-over-quarter to $76M.

Based on Highlander Partners's 13F filing for Q2 2022, filed 2 Aug 2022.